Our industry has risen to meet the challenge of COVID-19 and will deliver novel diagnostic tests, therapeutic treatments and preventative vaccines to combat and eradicate the virus. That’s why LSTCON will look to the future and showcase ways Tennessee companies and institutions are innovating cures for other diseases and conditions, as well as the state and federal policies that impact these innovations. We’ll also hold a virtual Venture Forum to learn about the latest technologies from some of our brightest Tennessee startups

And don’t miss a special session on November 17 with post election analysis and implications of the results for our industry.

LSTCON2020

LSTCON2020

AGENDA

Tuesday, October 27

4 – 5:30 PM CT

  • Tennessee Life Science Companies on the Front Lines of Cures: Scientific research and development don’t stop because of a pandemic. But COVID-19 has impacted companies building technologies for other conditions. Hear from a panel of innovators including Jenn Adams, Kayla Graff, Brian Laden, and Dan Liebler—representing everything from diagnostics and drugs to devices, and CMOs—about the challenges and opportunities they face in Tennessee to raise capital, maintain a workforce, and carry on their life-saving missions. 
  • Shaping the Future of Cures: The COVID-19 pandemic has swiftly reshaped the policy and regulatory environment. Investment continues to flood into biotech and biopharma companies who have virus-related applications. The regulatory environment is operating at a fast clip—dare we say warp speed. How will these changes impact future research and development? What of these changes, such as the reliance on telemedicine, will stick around? Hear from U.S. Rep. Phil Roe (R-1) and State Sen. Shane Reeves (R-14) about the role of policymakers in shaping this environment.

Wednesday, October 28

10:00 AM CT

  • Fund It. Are you in the process of raising capital for your life science company? Hear tips from Rob Readnour, Managing Director of Mountain Group Partners, and David Adair, Co-Founder & Managing Director at Solas BioVentures, for perfecting your pitch—and ensuring your science is rock solid.

11:00 AM CT

  • Build It. How do you grow an industry while maintaining a steadfast hold of your mission? Learn about the ways LST is expanding the life science industry in Tennessee and the important role you play in this effort with board chairman Ted Townsend.

1:00 PM CT

  • Secure It. Hear tips from Julie Lampley, Member in the Health Care and Life Sciences practice of Epstein Becker Green, and Danielle Sloane, Member of Bass, Berry & Sims, about how to navigate the complex maze of federal and state health care laws and regulations and ensure compliance in an ever-changing landscape.

2:00 PM CT

  • Translate It. How do you commercialize life-saving science? Get off the bench and hear from Dr. Larry Marnett, Dean of Basic Sciences at Vanderbilt University Medical Center, and Dr. Richard Magid, Vice President at the University of Tennessee Research Foundation at UT Health Science Center, about their experiences bringing drugs and therapies to market. 

4 – 5:30 PM CT

  • Venture Forum: Our annual pitch competition for life science startups, sponsored by Waller. 
  • LST Update and Voting: Listen in on LST’s priorities for the coming year and vote for our new board–including a new board chairman. Your voice (and vote) matter as a member!

Tuesday, November 17

4 – 5:00 PM CT

  • The 2020 Election: Outcomes and Outlook for the Life Science Industry